Search details
1.
p16 INK4A drives nonalcoholic fatty liver disease phenotypes in high fat diet fed mice through biliary E2F1/FOXO1/IGF-1 signaling.
Hepatology
; 78(1): 243-257, 2023 07 01.
Article
in English
| MEDLINE | ID: mdl-36799449
2.
Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC.
Gut
; 72(4): 671-685, 2023 04.
Article
in English
| MEDLINE | ID: mdl-35705368
3.
FXR Friend-ChIPs in the Enterohepatic System.
Semin Liver Dis
; 43(3): 267-278, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37442156
4.
Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes.
J Hepatol
; 78(1): 99-113, 2023 01.
Article
in English
| MEDLINE | ID: mdl-35987275
5.
Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis.
Am J Physiol Gastrointest Liver Physiol
; 324(1): G60-G77, 2023 01 01.
Article
in English
| MEDLINE | ID: mdl-36410025
6.
Melatonin receptor 1A, but not 1B, knockout decreases biliary damage and liver fibrosis during cholestatic liver injury.
Hepatology
; 75(4): 797-813, 2022 04.
Article
in English
| MEDLINE | ID: mdl-34743371
7.
Mast Cells Promote Nonalcoholic Fatty Liver Disease Phenotypes and Microvesicular Steatosis in Mice Fed a Western Diet.
Hepatology
; 74(1): 164-182, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33434322
8.
Mast Cells Regulate Ductular Reaction and Intestinal Inflammation in Cholestasis Through Farnesoid X Receptor Signaling.
Hepatology
; 74(5): 2684-2698, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34164827
9.
Inhibition of Secretin/Secretin Receptor Axis Ameliorates NAFLD Phenotypes.
Hepatology
; 74(4): 1845-1863, 2021 10.
Article
in English
| MEDLINE | ID: mdl-33928675
10.
Mast Cells Induce Ductular Reaction Mimicking Liver Injury in Mice Through Mast Cell-Derived Transforming Growth Factor Beta 1 Signaling.
Hepatology
; 73(6): 2397-2410, 2021 06.
Article
in English
| MEDLINE | ID: mdl-32761972
11.
Amelioration of Large Bile Duct Damage by Histamine-2 Receptor Vivo-Morpholino Treatment.
Am J Pathol
; 190(5): 1018-1029, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32142732
12.
Knockout of the Tachykinin Receptor 1 in the Mdr2-/- (Abcb4-/-) Mouse Model of Primary Sclerosing Cholangitis Reduces Biliary Damage and Liver Fibrosis.
Am J Pathol
; 190(11): 2251-2266, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32712019
13.
The interplay between mast cells, pineal gland, and circadian rhythm: Links between histamine, melatonin, and inflammatory mediators.
J Pineal Res
; 70(2): e12699, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-33020940
14.
Biliary damage and liver fibrosis are ameliorated in a novel mouse model lacking l-histidine decarboxylase/histamine signaling.
Lab Invest
; 100(6): 837-848, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32054995
15.
Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2-/- mice and human cholangiocarcinoma tumorigenesis.
Hepatology
; 68(3): 1042-1056, 2018 09.
Article
in English
| MEDLINE | ID: mdl-29601088
16.
Mast cells in liver disease progression: An update on current studies and implications.
Hepatology
; 75(1): 213-218, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34435373
17.
Doublecortin-Like Kinase Protein 1 in Cholangiocarcinoma: Is This the Biomarker and Target We Have Been Looking For?
Hepatology
; 73(1): 4-6, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33179783
18.
Functional Role of the Secretin/Secretin Receptor Signaling During Cholestatic Liver Injury.
Hepatology
; 72(6): 2219-2227, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32737904
19.
Characterization of individual bile acids in vivo utilizing a novel low bile acid mouse model.
Toxicol Sci
; 199(2): 316-331, 2024 May 28.
Article
in English
| MEDLINE | ID: mdl-38526215
20.
FXR and NASH: an avenue for tissue-specific regulation.
Hepatol Commun
; 7(5)2023 05 01.
Article
in English
| MEDLINE | ID: mdl-37058105